RA: Do JAK Inhibitors Increase Blood Clot Risk? RA: Do JAK Inhibitors Increase Blood Clot Risk?

An analysis of postmarket case reports for patients treated with tofacitinib or ruxolitinib hinted at a possible increased risk for pulmonary thrombosis, but not for VTE or PE. Experts are not convinced.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Rheumatology News Source Type: news